The global biopharmaceutical market saw a 2% increase in market capitalization in Q3 2024, led by growth from Bristol-Myers ...

TG Therapeutics, Inc. reported a modest Q3 beat and raised the full-year net sales guidance range for Briumvi by $7.5 million ...

The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor ...

Roche has said it plans to UK price its latest multiple sclerosis drug Ocrevus in line with its close rival from Novartis - aiming to undercut some established rivals. Approved in Europe earlier ...

President-elect Trump is projected to win the popular vote in the presidential election, a feat not achieved by a Republican candidate in 20 years. Current vote counts show Trump surpassing Vice ...

Another Trump term could spur Europe’s efforts to stand on its own, but it is far from clear its leaders will seize the moment this time. By Steven Erlanger Beijing is expecting more ...

Russians close to the Kremlin voiced optimism that Donald J. Trump could help end the war in Ukraine on Russia’s terms. Vladimir V. Putin said Mr. Trump’s remarks on ending the war “deserve ...

Roche has said it will continue with talks with UK health officials to bring its multiple sclerosis drug Ocrevus to NHS patients with primary progressive disease, after NICE said it was not cost ...

Federal officials are investigating a new outbreak of E. coli O121:H19. A source of the pathogen has not yet been identified. The investigation is in its early stages, and 33 patients have been ...

Nov. 1, 2024 — Microplastics have been steadily increasing in freshwater environments for decades and are directly tied to rising global plastic production since the 1950s, according to a new ...

Nov. 6, 2024 — New research is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized treatment ...